Navigation Links
Study Results Reveal alli(R) Patient Satisfaction Linked to Weight Loss Achieved; Not Treatment Effects
Date:10/22/2007

NEW ORLEANS and PITTSBURGH, Oct. 22 /PRNewswire-FirstCall/ -- Data presented at the 2007 Annual Scientific Meeting of NAASO, The Obesity Society, found that patient satisfaction with alli(R) (orlistat 60mg), the only FDA- approved, over-the-counter (OTC) weight loss product, was connected to the product's effectiveness in helping them lose weight, and not to potential gastrointestinal (GI) treatment effects. This is important because these data show that the weight loss achieved with alli strongly motivates subjects to continue treatment regardless if they are experiencing treatment effects.

In the study, very few subjects (<5%) stopped taking alli because of treatment effects and were able to maximize their weight loss. Interestingly, treatment effects were viewed by many alli users as a positive feedback tool that helps them become more aware of hidden fats in foods.

Many patients have reported significant weight loss and high satisfaction when following the alli weight loss plan. Treatment effects are characterized by predictable GI side effects when alli is taken with meals with too much fat. "Since having my first child, I have been carrying around extra weight and now I'm a mother of three," said Jaime Clear, a 28-year-old alli First Team member from Henderson, Nevada. "I committed to losing the weight with alli and have lost 20 pounds in 10 weeks. The treatment effects have been manageable and have kept me honest about my diet." The alli First Team is a group of 406 men and women that was formed after alli was approved by the FDA, and given the opportunity to use alli at no cost before it was available in stores.

This cumulative data analysis evaluated controlled and non-controlled studies on alli (orlistat 60mg) to examine the overall tolerability profile. The analysis of controlled studies shows that during the first week of treatment with alli, the overall incidence of most treatment effects was generally low (3% to 8%). In additio
'/>"/>

SOURCE GlaxoSmithKline Consumer Healthcare
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... Sept. 15, 2014 /PRNewswire-iReach/ -- "Spain Aesthetic Lasers ... key market data on the Spain Aesthetic Lasers ... in millions of US dollars, volume (in units) ... segments Invasive Body Contouring Devices (Laser-Assisted Liposuction (LAL) ... (RFAL) Devices, Ultrasound-Assisted Liposuction (UAL) Devices and Power ...
(Date:9/15/2014)... Sept. 15, 2014  Valeant Pharmaceuticals International, Inc. (NYSE: ... wholly owned subsidiary, Valeant Pharmaceuticals International, will redeem all ... its 6.75% Senior Notes due 2017, CUSIP Nos. 91911XAL8, ... and has mailed an irrevocable notice of redemption for ... copy of the irrevocable notice of redemption with respect ...
(Date:9/15/2014)... , Sept. 15, 2014 /PRNewswire-iReach/ -- MedicOne Medical Response, ... services, has been selected by Inc. Magazine as ... America. Photo - http://photos.prnewswire.com/prnh/20140914/145997 ... list identifies successful, privately-held companies with the largest ... Response, one of only two ambulance companies to ...
Breaking Medicine Technology:Spain Aesthetic Lasers and Energy Devices Market (LAL, RFAL, PAL, HIFU) Outlook to 2020 2Spain Aesthetic Lasers and Energy Devices Market (LAL, RFAL, PAL, HIFU) Outlook to 2020 3Spain Aesthetic Lasers and Energy Devices Market (LAL, RFAL, PAL, HIFU) Outlook to 2020 4Spain Aesthetic Lasers and Energy Devices Market (LAL, RFAL, PAL, HIFU) Outlook to 2020 5Valeant Announces Redemption of All of the Outstanding $500.0 Million Aggregate Principal Amount of its 6.75% Senior Notes due 2017 2MedicOne Medical Response Named to 2014 Inc. 5000 Fastest Growing Companies List 2MedicOne Medical Response Named to 2014 Inc. 5000 Fastest Growing Companies List 3
(Date:9/16/2014)... is the event of the year for the latest ... of the Acute Cardiovascular Care Association (ACCA) of the ... October in Geneva, Switzerland. , Monday 16 September ... the specialty of cardiology dealing with acute problems in ... and acute heart failure. The scientific programme is available ...
(Date:9/16/2014)... (PRWEB) September 16, 2014 According ... Market Research "Latin America Home Healthcare Market (By ... Healthcare Devices, Mobility Assist Devices and Medical Supplies; ... Infusion Therapy and Unskilled Home Healthcare Services) - ... 2014 - 2020" the Latin American Home Healthcare ...
(Date:9/16/2014)... VA (PRWEB) September 16, 2014 Norfolk, ... of delectable gluten-free and allergy friendly desserts, announced today ... for Breast Cancer Awareness Month this October. In support ... eliminating cancer, Lucy’s® will provide a charitable donation in ... one of the most common cancers among women in ...
(Date:9/16/2014)... HealthDay Reporter , MONDAY, Sept. 15, ... face a higher risk of developing an aggressive type of ... suggests. But, the study authors noted that it,s not ... should be concerned. Their study only found an association between ... prove cause and effect. "It is conceivable that, in ...
(Date:9/16/2014)... (PRWEB) September 16, 2014 Current students ... the Capstone Event in Yelm, Washington, Oct. 20-26 to ... the year and caps off the remarkable “Masters of ... world in Switzerland, Italy, Australia, South Korea, Mexico, and ... half price for children ages 6-19 and for seniors ...
Breaking Medicine News(10 mins):Health News:ACCA congress: Ensuring a rapid response to cardiac emergencies 2Health News:ACCA congress: Ensuring a rapid response to cardiac emergencies 3Health News:Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 2Health News:Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 3Health News:Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 4Health News:Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 5Health News:Lucy’s Joins Fight Against Breast Cancer With Launch Of Limited Edition Packaging And Charitable Donation 2Health News:Lucy’s Joins Fight Against Breast Cancer With Launch Of Limited Edition Packaging And Charitable Donation 3Health News:Male Pattern Baldness Tied to Prostate Cancer, Study Suggests 2Health News:Male Pattern Baldness Tied to Prostate Cancer, Study Suggests 3Health News:Ramtha School Presents Capstone Event in Yelm Oct. 20-26 2
... extensively drug-resistant tuberculosis (XDR TB) in the United States, ... and difficult-to-treat disease between 1993 and 2006, and 77 ... The study appears in the August 15 issue of ... California reports almost 3,000 cases of tuberculosis annually, the ...
... benefits are weighed , , WEDNESDAY, Aug. 13 (HealthDay ... suggests. , Would-be participants in an extramarital affair tend ... researchers from the University of New Hampshire (UNH) and ... the decision differ slightly between men and women, said ...
... Network Growing, BUFFALO, N.Y., Aug. 13 ... national, electronic healthcare network,and has announced the ... healthcare providers., (Logo: http://www.newscom.com/cgi-bin/prnh/20080813/NYW083LOGO ... Medina Memorial Health Care,System, and MedFirst Urgent ...
... and Two Rivers among Thomson ... MILWAUKEE, Aug. 13 Three Aurora Health Care facilities,are ... having,demonstrated the fastest, most consistent improvement over five consecutive,years., ... Medical Center of,Green Bay were ranked in the Thomson ...
... a,lazy Sunday with a great meal and relaxing spa treatments. Voda ... Sunday, from 12pm - 4pm, Voda Spa offers the taste and ... Brunch Massage $140 Brunch Scrub ... Choose from a selection of delicious dishes from our restaurant. All,brunches ...
... LAKE OSWEGO, Ore., Aug. 13 West Coast ... of LifeWorks Northwest, a,leading non-profit, community-based mental health ... pledge and a corporate gift. The donation,will sponsor ... Children and Youth Recreation Fund., Additionally, West ...
Cached Medicine News:Health News:Extensively drug-resistant tuberculosis found in California 2Health News:Men and Women Calculate Cost of Affairs 2Health News:Wolfson's HealthTransaction Network(R) Signs Four New Hospital Systems 2Health News:Three Aurora Hospitals Named Top Performers in National Thomson Reuters Annual Survey 2Health News:Three Aurora Hospitals Named Top Performers in National Thomson Reuters Annual Survey 3Health News:West Coast Bank Sponsors LifeWorks Northwest Programs for Children in Low-Income Housing Communities 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: